Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

COVID-19 Vaccine: A comprehensive status report
Simran Kaur, Vandana Gupta
Virus Research (2020) Vol. 288, pp. 198114-198114
Open Access | Times Cited: 853

Showing 1-25 of 853 citing articles:

High Rates of COVID-19 Vaccine Hesitancy and Its Association with Conspiracy Beliefs: A Study in Jordan and Kuwait among Other Arab Countries
Malik Sallam, Deema Dababseh, Huda Eid, et al.
Vaccines (2021) Vol. 9, Iss. 1, pp. 42-42
Open Access | Times Cited: 653
SARS-CoV-2 immunity: review and applications to phase 3 vaccine candidates
Gregory A. Poland, Inna G. Ovsyannikova, Richard B. Kennedy
The Lancet (2020) Vol. 396, Iss. 10262, pp. 1595-1606
Open Access | Times Cited: 608
Predictors of intention to vaccinate against COVID-19: Results of a nationwide survey
Jeanette B. Ruiz, Robert A. Bell
Vaccine (2021) Vol. 39, Iss. 7, pp. 1080-1086
Open Access | Times Cited: 598
Age-dependent Immune Response to the Biontech/Pfizer BNT162b2 Coronavirus Disease 2019 Vaccination
Lisa Müller, Marcel Andrée, Wiebke Moskorz, et al.
Clinical Infectious Diseases (2021) Vol. 73, Iss. 11, pp. 2065-2072
Open Access | Times Cited: 476
Aging, Immunity, and COVID-19: How Age Influences the Host Immune Response to Coronavirus Infections?
Varnica Bajaj, Nirupa Gadi, Allison P. Spihlman, et al.
Frontiers in Physiology (2021) Vol. 11
Open Access | Times Cited: 439
Lipid-Based Nanoparticles in the Clinic and Clinical Trials: From Cancer Nanomedicine to COVID-19 Vaccines
Thai Thanh Hoang Thi, Estelle J. A. Suys, Jung Seok Lee, et al.
Vaccines (2021) Vol. 9, Iss. 4, pp. 359-359
Open Access | Times Cited: 376
COVID-19 vaccines: rapid development, implications, challenges and future prospects
Shivaji Kashte, Arvind Gulbake, Saadiq F. El‐Amin, et al.
Human Cell (2021) Vol. 34, Iss. 3, pp. 711-733
Open Access | Times Cited: 362
COVID-19 Vaccine Frontrunners and Their Nanotechnology Design
Young Hun Chung, Veronique Beiss, Steven Fiering, et al.
ACS Nano (2020) Vol. 14, Iss. 10, pp. 12522-12537
Open Access | Times Cited: 323
An update on COVID-19 pandemic: the epidemiology, pathogenesis, prevention and treatment strategies
Hin Fung Tsang, Lawrence Chan, William C. Cho, et al.
Expert Review of Anti-infective Therapy (2020) Vol. 19, Iss. 7, pp. 877-888
Closed Access | Times Cited: 289
The COVID-19 pandemic face mask waste: A blooming threat to the marine environment
S. Selvakumar, Veeramuthu Ashokkumar, S Hariharan, et al.
Chemosphere (2021) Vol. 272, pp. 129601-129601
Open Access | Times Cited: 275
COVID-19: Characteristics and Therapeutics
Rameswari Chilamakuri, Saurabh Agarwal
Cells (2021) Vol. 10, Iss. 2, pp. 206-206
Open Access | Times Cited: 266
Role of nanotechnology behind the success of mRNA vaccines for COVID-19
Amit Khurana, Prince Allawadhi, Isha Khurana, et al.
Nano Today (2021) Vol. 38, pp. 101142-101142
Open Access | Times Cited: 227
Knowledge, acceptance and perception on COVID-19 vaccine among Malaysians: A web-based survey
Nurul Azmawati Mohamed, Hana Maizuliana Solehan, Mohd Dzulkhairi Mohd Rani, et al.
PLoS ONE (2021) Vol. 16, Iss. 8, pp. e0256110-e0256110
Open Access | Times Cited: 210
Genetics and genomics of SARS-CoV-2: A review of the literature with the special focus on genetic diversity and SARS-CoV-2 genome detection
Azadeh Rahimi, Azin Mirzazadeh, Soheil Tavakolpour
Genomics (2020) Vol. 113, Iss. 1, pp. 1221-1232
Open Access | Times Cited: 168
Age-dependent immune response to the Biontech/Pfizer BNT162b2 COVID-19 vaccination
Lisa Müller, Marcel Andrée, Wiebke Moskorz, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 157
Mistrust and Beliefs in Conspiracy Theories Differently Mediate the Effects of Psychological Factors on Propensity for COVID-19 Vaccine
Luca Simione, Monia Vagni, Camilla Gnagnarella, et al.
Frontiers in Psychology (2021) Vol. 12
Open Access | Times Cited: 123
Potential adverse effects of COVID19 vaccines among Iraqi population; a comparison between the three available vaccines in Iraq; a retrospective cross-sectional study
Hind B. Almufty, Shinah A. Mohammed, Arshad M. Abdullah, et al.
Diabetes & Metabolic Syndrome Clinical Research & Reviews (2021) Vol. 15, Iss. 5, pp. 102207-102207
Open Access | Times Cited: 118
Exploring public perceptions of the COVID-19 vaccine online from a cultural perspective: Semantic network analysis of two social media platforms in the United States and China
Chen Luo, Anfan Chen, Botao Cui, et al.
Telematics and Informatics (2021) Vol. 65, pp. 101712-101712
Open Access | Times Cited: 117
SARS-CoV-2 vaccines: Lights and shadows
Fabio Angeli, Antonio Spanevello, Gianpaolo Reboldi, et al.
European Journal of Internal Medicine (2021) Vol. 88, pp. 1-8
Open Access | Times Cited: 113
Varicella Zoster Virus Reactivation Following COVID-19 Vaccination: A Systematic Review of Case Reports
Konstantinos Katsikas Triantafyllidis, Panagiotis Giannos, Imran Tariq Mian, et al.
Vaccines (2021) Vol. 9, Iss. 9, pp. 1013-1013
Open Access | Times Cited: 111
Acceptability of COVID-19 Vaccination among Health Care Workers in Ghana
Martin Wiredu Agyekum, Grace Frempong Afrifa-Anane, Frank Kyei‐Arthur, et al.
Advances in Public Health (2021) Vol. 2021, pp. 1-8
Open Access | Times Cited: 110
A single blind, placebo-controlled randomized study of the safety, reactogenicity and immunogenicity of the “EpiVacCorona” Vaccine for the prevention of COVID-19, in volunteers aged 18–60 years (phase I–II)
Alexander B. Ryzhikov, Alexander B. Ryzhikov, M. P. Bogryantseva, et al.
Russian Journal of Infection and Immunity (2021) Vol. 11, Iss. 2, pp. 283-296
Open Access | Times Cited: 106
Structural and non-structural proteins in SARS-CoV-2: potential aspects to COVID-19 treatment or prevention of progression of related diseases
Sareh Kakavandi, Iman Zare, Maryam Vaezjalali, et al.
Cell Communication and Signaling (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 68
COVID-19 vaccines adverse events: potential molecular mechanisms
Malamatenia Lamprinou, Athanasios Sachinidis, Εleni Stamoula, et al.
Immunologic Research (2023) Vol. 71, Iss. 3, pp. 356-372
Open Access | Times Cited: 64
The landscape of nanoparticle-based siRNA delivery and therapeutic development
Muhammad Moazzam, Jun Zhang, Abid Hussain, et al.
Molecular Therapy (2024) Vol. 32, Iss. 2, pp. 284-312
Closed Access | Times Cited: 52
Page 1 - Next Page

Scroll to top